日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Evaluating the Impact of Hepatic or Renal Impairment on Tanimilast (CHF6001) Pharmacokinetics: Two Open-Label, Parallel-Group, Single-Center Studies

评估肝肾功能损害对塔尼米司特(CHF6001)药代动力学的影响:两项开放标签、平行组、单中心研究

Piccinno, Annalisa; Pittelli, Maria Gloria; Balzano, Deborah; Rizzo, Elisa; Bellatti, Pooja; Rostello, Chiara; Emirova, Aida

A Moderate Decrease in ADAMTS13 Activity Correlates with the Severity of STEC-HUS

ADAMTS13活性中度下降与STEC-HUS的严重程度相关。

Emirova, Khadizha M; Orlova, Olga M; Chichuga, Ekaterina M; Muzurov, Alexander L; Avdonin, Piotr P; Avdonin, Pavel V

The Role of the Complement System in the Pathogenesis of Infectious Forms of Hemolytic Uremic Syndrome

补体系统在感染性溶血性尿毒综合征发病机制中的作用

Avdonin, Piotr P; Blinova, Maria S; Generalova, Galina A; Emirova, Khadizha M; Avdonin, Pavel V

COPD patients with chronic bronchitis and higher sputum eosinophil counts show increased type-2 and PDE4 gene expression in sputum

慢性阻塞性肺病患者,若伴有慢性支气管炎且痰液嗜酸性粒细胞计数较高,则痰液中2型磷酸二酯酶和PDE4基因表达增加。

Singh, Dave; Bassi, Michele; Balzano, Deborah; Lucci, Germano; Emirova, Aida; Anna Nandeuil, Marie; Jellema, Gera; Afolabi, Ebenezer K; Leaker, Brian; Kornmann, Oliver; Michael Beeh, Kai; Watz, Henrik; Govoni, Mirco

COPD sputum eosinophils: relationship to blood eosinophils and the effect of inhaled PDE4 inhibition

慢性阻塞性肺病痰嗜酸性粒细胞:与血液嗜酸性粒细胞的关系及吸入PDE4抑制剂的作用

Singh, Dave; Watz, Henrik; Beeh, Kai Michael; Kornmann, Oliver; Leaker, Brian; Colgan, Brendan; Lucci, Germano; Emirova, Aida; Nandeuil, Marie Anna; Santoro, Debora; Balzano, Deborah; Govoni, Mirco

Sputum and blood transcriptomics characterisation of the inhaled PDE4 inhibitor CHF6001 on top of triple therapy in patients with chronic bronchitis

在慢性支气管炎患者的三联疗法基础上加用吸入型PDE4抑制剂CHF6001,进行痰液和血液转录组学特征分析

Govoni, Mirco; Bassi, Michele; Vezzoli, Stefano; Lucci, Germano; Emirova, Aida; Nandeuil, Marie Anna; Petruzzelli, Stefano; Jellema, Gera L; Afolabi, Ebenezer K; Colgan, Brendan; Leaker, Brian; Kornmann, Oliver; Beeh, Kai Michael; Watz, Henrik; Singh, Dave

Efficacy and safety of CHF6001, a novel inhaled PDE4 inhibitor in COPD: the PIONEER study

CHF6001(一种新型吸入式PDE4抑制剂)治疗慢性阻塞性肺疾病的疗效和安全性:PIONEER研究

Singh, Dave; Emirova, Aida; Francisco, Catherine; Santoro, Debora; Govoni, Mirco; Nandeuil, Marie Anna

Effect of the inhaled PDE4 inhibitor CHF6001 on biomarkers of inflammation in COPD

吸入型PDE4抑制剂CHF6001对慢性阻塞性肺疾病炎症生物标志物的影响

Singh, Dave; Beeh, Kai Michael; Colgan, Brendan; Kornmann, Oliver; Leaker, Brian; Watz, Henrik; Lucci, Germano; Geraci, Silvia; Emirova, Aida; Govoni, Mirco; Nandeuil, Marie Anna

Dose-response of an extrafine dry powder inhaler formulation of glycopyrronium bromide: randomized, double-blind, placebo-controlled, dose-ranging study (GlycoNEXT)

格隆溴铵超细干粉吸入剂的剂量反应:随机、双盲、安慰剂对照、剂量范围研究(GlycoNEXT)

Beeh, Kai M; Emirova, Aida; Prunier, Hélène; Santoro, Debora; Nandeuil, Marie Anna

Recovery of renal function after long-term dialysis and resolution of cardiomyopathy in a patient with aHUS receiving eculizumab

接受依库珠单抗治疗的非典型溶血性尿毒综合征(aHUS)患者,长期透析后肾功能恢复,心肌病缓解

Emirova, Khadizha; Volokhina, Elena; Tolstova, Evgenia; van den Heuvel, Bert